GynecologyGynecology2079-56962079-5831Consilium Medicum28448Research ArticleThe results of the research on cimicifuga extract impact in systematic and local use on structural and functional skin rates in perimenopause, menopause and postmenopauseYutskovskayaYa Ayutskovskaya@yandex.ruSukhanovaA S-Clinic professor YutskovskayaN.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation1512201517641009042020Copyright © 2015, Consilium Medicum2015Results of studying of efficiency and safety of the combination of medicine Ci-Clim and cosmetic product Ci-Clim (JSC EVALAR, Russia), containing extract of cimicifuga racemosa, for the purpose of correction of structural and functional changes of skin of women in the perimenopausal, menopausal and postmenopausal period are presented. Materials and methods. Under supervision there were 15 women aged from 41 till 56 years, who had any signs of a climacteric syndrome. Research of the morphologic and functional skin characteristics (including measurement of thickness of derma and epidermis by means of ultrasound, the characteristic of structure, humidity, elasticity and visual appearance of skin), and also an assessment of quality of life by means of SF-36 questionnaire was conducted. Patients were treated with combination of medicine Ci-Clim 1 tablet 2 times per day during meal within 12 months, and cosmetic product Ci-Clim on the face (1 ml 2 times a day) daily within 12 months. Repeated visits were performed monthly, an assessment of the morphological and functional properties of the skin were done at 6 and 12 months.Results. Significant reduction of thickness of epidermis and increase in thickness of derma, and also increase of skin humidity and elasticity were noted at 6 and 12 months. Visual characteristics of skin improved. Quality of life of postmenopausal women improved as well as the skin characteristics. Conclusion. Application of the combination of medicine Ci-Clim and cosmetic product Ci-Clim, containing herbal extracts is highly effective, safe and well tolerated drug that allows to achieve effect in treatment of involutional changes of skin, improving an emotional state and quality of life of women.Ci-Climclimacteric syndromeskincimicifugaphytoestrogensклимактерический синдромкожацимицифугафитоэстрогенылекарственное средство Ци-Клим[Calleja-Agius J, Muscat-Baron Y, Brincat M.P. Skin ageing. Menopause Int. 2007; 13 (2): 60-4.][Brincat M.P. Hormone Replacement Therapy and the Skin. Lancaster: Parthenon, 2001.][Hall G.K, Phillips T.J. Skin and hormone therapy. Clin Obstet Gynecol 2004; 47: 437-49.][Brincat M.P, Baron Y.M, Galea R. Estrogens and the skin. Climacteric 2005; 8 (2): 110-23.][Brincat M, Moniz C.F, Kabalan S et al. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987; 94 (2): 126-9.][Castelo-Branco C, Duran M, González-Merlo J. Skin collagen changes related to age and hormone replacement therapy. Maturitas 1992; 15 (2): 113-9.][Shah M.G, Maibach H.I. Estrogen and skin. An overview. Am J Clin Dermatol 2001; 2 (3): 143-50.][Shuster S. Osteoporosis, a unitary hypothesis of collagen loss in skin and bone. Med Hypotheses 2005; 65 (3): 426-32.][Bolognia J.L, Braverman I.M, Rousseau M.E, Sarrel P.M. Skin changes in menopause.Maturitas 1989; 11 (4): 295-304.][Savvas M, Bishop J, Laurent G et al. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993; 100 (2): 154-6.][Schmidt J.B, Binder M, Demschik G et al. Treatment of skin aging with topical estrogens.Int J Dermatol 1996; 35 (9): 669-74.][Varila E, Rantala I, Oikarinen A et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102 (12): 985-9.][Punnonen R, Vaajalahti P, Teisala K. Local oestriol treatment improves the structure of elastic fibers in the skin of postmenopausal women Ann Chir Gynaecol Suppl 1987; 202: 39-41.][Waller J.M, Maibach H.I. Age and skin structure and function, a quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and structure. Skin Res Technol 2006; 12 (3): 145-54.][Sator P.G, Schmidt J.B, Sator M.O et al. The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas 2001; 39 (1): 43-55.][Maheux R, Naud F, Rioux M et al. A randomized, double - blind, placebo - controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 1994; 170 (2): 642-9.][Sumino H, Ichikawa S, Abe M et al. Effects of aging, menopause, and hormone replacement therapy on forearm skin elasticity in women. J Am Geriatr Soc 2004; 52 (6): 945-9.][Piérard G.E, Letawe C, Dowlati A, Piérard-Franchimont C. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995; 43 (6): 662-5.][Castelo-Branco C, Figueras F, de Osaba M.J.M, Vanrell J.A. Facial wrinkling in postmenopausal women. Effects of smoking status and hormone replacement therapy. Maturitas 1998; 29 (1): 75-86.][Haenggi W, Linder H.R, Birkhaeuser M.H, Schneider H. Microscopic findings of the nail - fold capillaries - dependence on menopausal status and hormone replacement therapy. Maturitas. 199; 22 (1): 37-46.][Arora S, Veves A, Caballaro A.E et al. Estrogen improves endothelial function. J Vasc Surg 1998; 27 (6): 1141-6; discussion 1147.][Nair P.A. Dermatosis associated with menopause. J Midlife Health 2014; 5 (4): 168-75.][Клинические рекомендации. Акушерство и гинекология. Под ред. В.Н.Серова, Г.Т.Сухих. Изд. 4-е, перераб. и доп. М.: ГЭОТАР-Медиа, 2014.][Wines N, Willsteed E. Menopause and the skin. Australas J Dermatol 2001; 42 (3): 149-8; quiz. 159.][Лорен С. Женщины и красота. М.: Вагриус, 2001.][Antiaging Products and Services: The Global Market. BCC Research, 2013 - 164 pages. Интернет - ресурс http://www.bccresearch.com/ market-research/healthcare/antiaging-products-services-hlc060b.html. Дата обращения 21.06.2015.][Foster S. Black cohosh: Cimicifuga racemosa: a literature review. Herbalgram. 1999; 45: 35-49.][Mahady G.B. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 2005; 4 (3): 177-84.][Грицюк М. 50 плюс новая жизнь. «Российская газета» - Федеральный вып. №5622 (246) Интернет - ресурс http://www.rg.ru/ 2011/11/02/trud.html. Дата обращения 21.06.2015.][García-Pérez M.A, Pineda B, Hermenegildo C et al. Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line. Fertil Steril. 2009; 91 (Suppl. 4): 1347-50.][Stoll W. Phytotherapeutikum beeinflusst atrophisches Vaginalepithel: Doppelblind - versuch Cimicifuga vs. Ostrogenpraparat. Therapeutikon 1987; 1: 23-31.][Lehmann-Willenbrock E, Riedel H.H. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zentralbl Gynakol 1988; 110 (10): 611-8.][Warnecke G. Influencing menopausal symptoms with a phytotherapeutic agent. Med Welt 1985; 36: 871-4.][Liske E, Hänggi W, Henneicke - von Zepelin H.H et al. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002; 11 (2): 163-74.][Daiber W. Klimakterische beschwerden: ohne hormone zum erfolg. Ӓrztliche Praxis 1983; 35: 1946-7.][Pethӧ A. Klimakterische beschwerden: umstellung einer hormonbehandlung auf ein pflanzliches gynӓkologikum mӧglich? Ӓrztliche Praxis 1987; 38: 1551-3][Chen J, Gao H, Li Q et al. Efficacy and safety of remifemin on peri - menopausal symptoms induced by post - operative GnRH-a therapy for endometriosis: a randomized study versus tibolone. Zhonghua Yi Xue Za Zhi 2013; 93 (8): 600-2.][Huang Y.X, Song L, Zhang X et al. Clinical study of combined treatment of remifemin and paroxetine for perimenopausal depression. Zhonghua Yi Xue Za Zhi 2013; 93 (8): 600-2.][Juliá Mollá M.D, García-Sánchez Y, Romeu Sarri A et al. Cimicifuga racemosa treatment and health related quality of life in post - menopausal Spanish women. Gynecol Endocrinol 2009; 25 (1): 21-6.][Ross S.M. Menopause: a standardized isopropanolic black cohosh extract (remifemin) is found to be safe and effective for menopausal symptoms. Holist Nurs Pract 2012; 26 (1): 58-61.][Drewe J, Zimmermann C, Zahner C. The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints - an observational study. Phytomedicine. 2013; 20 (8-9): 659-66.][Ayres D.C, Loike J.D. Lignans. Chemical, biological and clinical properties. Eds. J.D.Phillllipson, D.C.Ayres, H.Baxter. Chemistry & Pharmacology of Natural Products. Cambridge: University Press, 1990.][Ботоева Е.А. К вопросу о фитоэстрогенах (обзор литературы). Бюллетень ВСНЦ СО РАМН. 2010. Гинекология. 2013; 15 (1): 85-92.][Кузнецова И.В. Растительные препараты в климактерии: многообразие и разумный выбор. Эффективная фармакотерапия. 2011; 2: 50-4.][Кузнецова И.В., Успенская Ю.Б. Применение фитоэстрогенов у женщин в период менопаузального перехода и постменопаузе. Эффективная фармакотерапия. 2013; 52: 44-51.][Reame N.E, Lukacs J.L, Padmanabhan V et al. Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause 2008; 15 (5): 832-40.][Иванова О.В., Усольцева Е.Н., Брюхина Е.В. Клиническая эффективность и динамика качества жизни у женщин с климактерическим синдромом, принимающих фитоэстрогены. Мед. наука и образ. Урала; 2013. 14 (1): 22-5.][Татарова Н.А., Линде В.А., Жидкова Е.В., Сохадзе Х.С. Негормональная коррекция климактерических расстройств в пери - и пост - менопаузе. Эффективная фармакотерапия. 2009; 17: 12-5.][Moreira A.C, Silva A.M, Santos M.S, Sardão V.A. Phytoestrogens as alternative hormone replacement therapy in menopause: What is real, what is unknown. J Steroid Biochem Mol Biol 2014; 143: 61-71.][Chen M.N, Lin C.C, Liu C.F. Efficacy of phytoestrogens for menopausal symptoms: a meta - analysis and systematic review. Climacteric 2015; 18 (2): 260-9.][Инструкция по медицинскому применению препарата Ци - клим, ЗАО «Эвалар», Россия. Регистрационное удостоверение № ЛСР-006592/09.][Ehrlich M, Rao J, Pabby A, Goldman M.P. Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and l - ascorbic acid. Dermatol Surg 2006; 32 (5): 618-25.]